| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |